Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Subpart IVJ - Clinical – Obstetrics and Gynecology
from Part IV - Clinical
Published online by Cambridge University Press: 31 March 2017
Edited by
Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 284 - 290Publisher: Cambridge University PressPrint publication year: 2017
References
References
Centers for Disease Control and Prevention. (2011). Diseases Characterized by Urethritis and Cervicitis. URL: www.cdc.gov/std/treatment/2010/urethritis-and-cervicitis.htm.Google Scholar
Chesson, HW, Collins, D, Koski, K. Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States. Cost Effectiveness and Resource Allocation. 2008; 6:10.CrossRefGoogle ScholarPubMed
Sutton, MY, Sternberg, M, Zaidi, A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985–2001. Sex Transmitted Disease. 2005; 32(12): 778–784.CrossRefGoogle ScholarPubMed
Gradison, M. Pelvic inflammatory disease. American Family Physician. 2012; 85(8): 791–796.Google ScholarPubMed
Workowski, KA, Berman, S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010 [published correction appears in MMWR Morb Mortal Wkly Rep. 2011; 60(1):18].MMWR Recomm Rep. 2010; 59(RR-12):1–110.Google Scholar
Ness, RB, Soper, DE, Holley, RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. American Journal of Obstetrics and Gynecology. 2002; 186: 929–937.5).CrossRefGoogle ScholarPubMed
References
Daniels, RV, McCuskey, C. (2003). Abnormal vaginal bleeding in the nonpregnant patient. Emergency Medicine Clinics of North America, 21 : 751–772.CrossRefGoogle ScholarPubMed
Morrison, L, Spence, J. (2000). Vaginal bleeding and pelvic pain in the nonpregnant patient. In: Emergency Medicine: A Comprehensive Guide. 5th edition. St. Louis, MO: McGraw-Hill: 669–680.Google Scholar
Munro, MG. (2001). Dysfunctional uterine bleeding: advances in diagnosis and treatment. Current Opinion in Obstetrics and Gynecology, 13: 475–489.CrossRefGoogle ScholarPubMed
Buckingham, K, Fawdry, A Fothergill, D. (1999). Management of vaginal bleeding presenting to the accident and emergency department. Journal of Accident and Emergency Medicine, 16(2): 130–135.CrossRefGoogle Scholar
References
ACOG. American College of Obstetrics and Gynecology Practice Bulletin: nausea and vomiting of pregnancy. Obstet Gynecol. 2004;103(4):803–814.CrossRefGoogle Scholar
Lacroix, R, Eason, E, Melzack, R. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000; 182(4):931–937.CrossRefGoogle ScholarPubMed
Bailit, JL. Hyperemesis gravidarium: epidemiologic findings from a large cohort. Am J Obstet Gynecol. 2005; 193(3 Pt 1):811–814.CrossRefGoogle ScholarPubMed
Fell, DB, Dodds, L, Joseph, KS, et al. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol. 2006; 107(2 Pt 1):277–284.CrossRefGoogle ScholarPubMed
Dodds, L, Fell, DB, Joseph, KS, et al. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol. 2006; 107(2 Pt 1):285–292.CrossRefGoogle ScholarPubMed
Holmgren, C, Aagaard-Tillery, KM, Silver, RM, et al. Hyperemesis in pregnancy: an evaluation of treatment strategies with maternal and neonatal outcomes. Am J Obstet Gynecol 2008; 198(1):56.e1–4.CrossRefGoogle ScholarPubMed
Tan, JY, Loh, KC, Yeo, GS, et al. Transient hyperthyroidism of hyperemesis gravidarum. BJOG 2002; 109(6):683–688.CrossRefGoogle ScholarPubMed
Goodwin, TM. Hyperemesis gravidarum. Obstet Gynecol Clin North Am. 2008; 35(3):401–417, viii.CrossRefGoogle ScholarPubMed
Matok, I, Gorodischer, R, Koren, G, et al. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. 2009; 2528–2535.CrossRefGoogle Scholar
Safari, HR, Alsulyman, OM, Gherman, RB, et al. Experience with oral methylprednisolone in the treatment of refractory hyperemesis gravidarum. Am J Obstet Gynecol. 1998; 178(5):1054–1058.CrossRefGoogle ScholarPubMed